Skip to main content

Table 2 Histopathological features of subungual benign melanocytic proliferation and subungual melanoma in situ

From: Cyclin D1 and PRAME expression in distinguishing melanoma in situ from benign melanocytic proliferation of the nail unit

Features

Subungual benign melanocytic proliferation (= 14), n (%)

Subungual Melanoma in situ (= 13), n (%)

p-value

Melanocyte density

  

0.182

 ≤ 30 cells/mm

10 (71.4)

6 (46.2)

 

 > 30 cells/mm

4 (28.6)

7 (53.8)

Confluency

  

< 0.001*

 Yes

5 (35.7)

13 (100.0)

 

 No

9 (64.3)

0 (0.0)

Pagetoid melanocytosis

  

0.006*

 Yes

6 (42.9)

12 (92.3)

 

 No

8 (57.1)

1 (7.7)

Inflammation

  

0.883

 Yes

5 (35.7)

5 (38.5)

 

 No

9 (64.3)

8 (61.5)

Atypia

  

< 0.001*

 No

6 (42.9)

0 (0.0)

 

 Mild

6 (42.9)

3 (23.1)

 Moderate

2 (14.3)

5 (38.5)

 Severe

0 (0.0)

5 (38.5)

Melanophage

  

0.516

 Yes

8 (57.1)

9 (69.2)

 

 No

6 (42.9)

4 (30.8)

Melanin pigment

  

1.000

 Basilar

4 (28.6)

4 (30.8)

 

 Entire

10 (71.4)

9 (69.2)

cyclin D1

  

1.000

 Positive

4 (28.6)

3 (23.1)

 

 Negative

7 (71.4)

9 (66.9)

PRAME

  

<0.001a

 Positive

1 (7.1)

10 (76.9)

 

 Negative

13 (92.9)

3 (23.1)

  1. Abbreviations: PRAME PReferentially expressed Antigen in MElanoma
  2. aStatistically significant